Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of zinc fluconazole decavanadate compound and its application

A zinc fluconazole decavanadate compound and molecular technology, applied in the field of medicinal chemistry, can solve the problems of few types of antifungal drugs, increased drug resistance and the like

Active Publication Date: 2021-04-06
JILIN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to solve the problem of fewer types of antifungal drugs and increased drug resistance, and provide a zinc fluconazole decavanadate hybrid compound and its preparation method and application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of zinc fluconazole decavanadate compound and its application
  • A kind of zinc fluconazole decavanadate compound and its application
  • A kind of zinc fluconazole decavanadate compound and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1 Preparation of zinc fluconazole decavanadate compound ZnFLC

[0027] Synthesis of ZnFLC:

[0028] 1) Zn(OAc) 2 2H 2 O 0.2 mmol, NaVO 3 Add 0.36 mmol and fcz0.1 mmol to 7mL water and stir for 1 hour, put it into a polytetrafluoroethylene reaction kettle, put it in an oven at 120 ℃ for 6 days, and slowly cool to room temperature to form orange crystal Zn 3 (fcz) 6 V 10 o 28 10H 2 O, the yield is 68.9%.

[0029] 2) Characterization of ZnFLC

[0030]The single crystal data for the zinc fluconazole decavanadate compound were collected on a German Bruker X-ray diffractometer (singlecrystal X-ray diffraction), 300K, MoK. rays (λ=0.71073Å). Calibration is performed using φ scans. And the crystal structure was solved by the direct method through the SHELEXL-97 program, and refined by the full matrix least squares method SHELEXL-97. The temperature factors for non-hydrogen atoms were corrected for anisotropy. The detailed crystal determination data are sho...

Embodiment 2

[0033] Embodiment 2 Culture medium preparation

[0034] 1. SDA medium: Add 39g of SDA powder into 1000ml of purified water, heat and dissolve at 115°C for 30 minutes, and sterilize by autoclaving. When the temperature of the medium drops to about 50°C, pour it into a sterilized petri dish to make a plate, Isolation and storage of strains;

[0035] 2. SDB medium: Add 24g of SDB powder to 1000ml of purified water, heat and dissolve at 115°C for 30 minutes, sterilize by autoclaving, store in centrifuge tubes after culture, and enrich and activate the strain;

[0036] 3. RPMI-1640 liquid medium: 10.4g RPMI-1640 powder and 34.53g MOPS, add 900ml sterile distilled water, stir gently until dissolved, adjust the pH value to 7.0 with 1M NaOH at 25°C, and adjust the volume to 1000ml , sterilized by filtration with a 0.22 μm microporous membrane, aliquoted into sterile bottles, and stored at -20°C for later use.

Embodiment 3

[0037] Example 3 strain activation

[0038] Add 0.2ml of SDB liquid base to the freeze-dried strain tube, suspend it sufficiently to make a bacterial suspension, and take 0.1ml of the liquid to activate the strain on the SDA plate and slant medium at 35°C and humidity 60%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a zinc fluconazole decavanadate compound, which is prepared by the following method: Zn(OAc) 2 2H 2 O 0.1~0.3 mmol, NaVO 3 Add 0.3~0.4mmol and fcz0.0.5~1.5 mmol into 5~9mL water, stir for 0.5~1.5 hours; put it into a polytetrafluoroethylene reaction kettle, put it in an oven, the temperature is 115~125°C, and the constant temperature time is 5~7 days. Cool slowly to room temperature; orange-yellow crystalline Zn is formed 3 (fcz) 6 V 10 o 28 10H 2 O, the yield was 68.9%; 2MIC 80 The content of ergosterol in the zinc fluconazole decavanadate compound group was 0.60±0.028mg / mL, which was reduced by 91.95% compared with the control group; Zn 3 (fcz) 6 V 10 o 28 10H 2 O has the effect of promoting the high expression of ERG11, which is 14.391 times that of the control group; the present invention uses hydrothermal synthesis technology to prepare a new type of zinc fluconazole decavanadate compound, which has excellent antifungal activity, and is not only used for anti-human In addition to fungal infection, it can also be used in the fields of coatings, anticorrosion and food packaging.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry, in particular to a preparation method and application of a zinc fluconazole decavanadate compound. Background technique [0002] Fungal infection is a serious threat to human health. Fungal infectious diseases mainly include superficial mycosis, skin mycosis, subcutaneous tissue mycosis and systemic mycosis. Superficial fungal diseases are widespread and spread all over the world, and they are also common and frequently-occurring diseases in my country. Although the fatality rate is low, it seriously reduces the quality of life. It is widely harmful, contagious, easy to relapse, and difficult to cure. The prevalence rate in the population is about 47.6%. With the increasing number of immunocompromised patients such as patients with AIDS, diabetes and malignant tumors, the extensive application of broad-spectrum antibiotics, corticosteroids, and chemotherapy drugs, the development of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D249/08A61K31/555A61P31/10A01N55/02A01P3/00
CPCA01N55/02A61P31/10C07D249/08
Inventor 齐燕飞郭栓丽赵明明田蕊张博玉
Owner JILIN UNIV